Insider · CIK 0001895958
Shelley Chu
Files at ODTX (Odyssey Therapeutics, Inc.), HLVX (HilleVax, Inc.). First filing May 11, 2026, latest May 11, 2026.
In brief
Shelley Chu files SEC Form 4 as director at ODTX (Odyssey Therapeutics, Inc.), and also at HLVX (HilleVax, Inc.). Since May 11, 2026, Shelley Chu has reported 1 open-market buy worth $200k and 0 open-market sells worth $0, the latest filed on May 11, 2026.
A track record needs three past buys with six months of prices behind them; Shelley Chu has 0, so none is measured yet.
The newest scored trade: bought $200k of ODTX on May 11, 2026, filed May 11, 2026, scored 50 (moderate). In the last 12 months: 1 buy worth $200k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ODTX: Odyssey Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Odyssey Therapeutics, Inc. | $200k 11,111 shares | - | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ODTX Odyssey Therapeutics, Inc. | POpen-market purchase Common Stock | +11,111 | $18.00 | $200k | 11,111 | May 11, 2026 |
| Sep 17, 2025 | HLVX HilleVax, Inc. | UTender of shares Common Stock | -17,199 | - | - | 0 | Sep 17, 2025 |
| Jun 23, 2025 | HLVX HilleVax, Inc. | AGrant or award Common Stock | +17,199 | $0.00 | $0 | 17,199 | Jun 25, 2025 |
| Jun 6, 2024 | HLVX HilleVax, Inc. | AGrant or award Stock Optionderivative | +22,500 | $0.00 | $0 | 22,500 | Apr 30, 2025 |
Questions about Shelley Chu
Answered from the filings on this page, as of the latest one.
Is Shelley Chu buying or selling?
In the last 12 months Shelley Chu reported 1 open-market buy worth $200k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $200k of ODTX on May 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Shelley Chu's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Shelley Chu has 0.
Where does Shelley Chu file Form 4?
Shelley Chu has filed Form 4 at ODTX (Odyssey Therapeutics, Inc.); HLVX (HilleVax, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.